Literature DB >> 32122201

Association between insulin resistance and risk of atrial fibrillation in non-diabetics.

Yonggu Lee1, Sung Joo Cha2, Jung-Hwan Park3, Jeong-Hun Shin1, Young-Hyo Lim2, Hwan-Cheol Park1, Jinho Shin2, Chun Ki Kim4, Jin-Kyu Park2.   

Abstract

AIMS: Previous studies from Western countries have been unable to demonstrate a relationship between insulin resistance and new-onset atrial fibrillation. We aimed to evaluate this relationship in the nondiabetic Asian population.
METHODS: Between 2001-2003, 8175 adults (mean age 51.5 years, 53% women) without both existing atrial fibrillation and diabetes and with insulin resistance measures at baseline were enrolled and were followed by biennial electrocardiograms thereafter until 2014. We constructed multivariable-adjusted Cox proportional hazard models for risk of incident atrial fibrillation.
RESULTS: Over a median follow-up of 12.3 years, 136 participants (1.89/1000 person-years) developed atrial fibrillation. Higher homeostasis model assessment of insulin resistance (HOMA-IR) was independently associated with newly developed atrial fibrillation (hazard ratio 1.61, 95% confidence interval 1.14-2.28). Atrial fibrillation development increased at the HOMA-IR levels approximately between 1-2.5, and then plateaued afterwards (p = 0.031).
CONCLUSION: There is a significant relationship between insulin resistance and atrial fibrillation development independent of other known risk factors, including obesity in a nondiabetic Asian population.

Entities:  

Keywords:  Insulin resistance; atrial fibrillation; epidemiology; obesity

Year:  2020        PMID: 32122201     DOI: 10.1177/2047487320908706

Source DB:  PubMed          Journal:  Eur J Prev Cardiol        ISSN: 2047-4873            Impact factor:   7.804


  6 in total

1.  The pre-ablation triglyceride-glucose index predicts late recurrence of atrial fibrillation after radiofrequency ablation in non-diabetic adults.

Authors:  Qinghui Tang; Xiao-Gang Guo; Qi Sun; Jian Ma
Journal:  BMC Cardiovasc Disord       Date:  2022-05-14       Impact factor: 2.174

2.  Cumulative burden of metabolic syndrome and its components on the risk of atrial fibrillation: a nationwide population-based study.

Authors:  Hyo-Jeong Ahn; Kyung-Do Han; Eue-Keun Choi; Jin-Hyung Jung; Soonil Kwon; So-Ryoung Lee; Seil Oh; Gregory Y H Lip
Journal:  Cardiovasc Diabetol       Date:  2021-01-19       Impact factor: 9.951

3.  Estimated glucose disposal rate and risk of stroke and mortality in type 2 diabetes: a nationwide cohort study.

Authors:  Alexander Zabala; Vladimer Darsalia; Marcus Lind; Ann-Marie Svensson; Stefan Franzén; Björn Eliasson; Cesare Patrone; Magnus Jonsson; Thomas Nyström
Journal:  Cardiovasc Diabetol       Date:  2021-10-06       Impact factor: 9.951

4.  Triglyceride-Glucose Index and New-Onset Atrial Fibrillation in ST-Segment Elevation Myocardial Infarction Patients After Percutaneous Coronary Intervention.

Authors:  Yang Ling; Cong Fu; Qun Fan; Jichun Liu; Ling Jiang; Shengxing Tang
Journal:  Front Cardiovasc Med       Date:  2022-03-08

5.  Association between Age of Onset of Hypertension and Incident Atrial Fibrillation.

Authors:  Yonggu Lee; Jeong-Hun Shin; Byung Sik Kim; Hyungdon Kook; Woohyeun Kim; Ran Heo; Young-Hyo Lim; Jinho Shin; Chun Ki Kim; Jin-Kyu Park
Journal:  J Pers Med       Date:  2022-07-21

Review 6.  Metabolic Inflexibility as a Pathogenic Basis for Atrial Fibrillation.

Authors:  Xinghua Qin; Yudi Zhang; Qiangsun Zheng
Journal:  Int J Mol Sci       Date:  2022-07-27       Impact factor: 6.208

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.